Marvin Slosman Reports 5.18% Stake in InspireMD, Inc. via Equity Awards and Direct Purchase

On April 24, 2026, Marvin Slosman, the Chief Executive Officer and a member of the Board of Directors of InspireMD, Inc. (NSPR), filed a Schedule 13D reporting a 5.18% beneficial ownership stake in the company. This filing follows an event on January 22, 2026, marking a significant increase from a previously reported 0% position. The reported holdings consist of 2,556,760 shares of common stock, which includes 16,722 shares held directly, over 1.8 million restricted stock units (RSUs) that are currently exercisable or will become so within 60 days, and 696,005 shares issuable upon the exercise of stock options. Most of these securities were acquired as equity compensation for his service as an executive, with only 10,330 shares purchased using personal funds in a July 2025 private placement. As CEO, Slosman may influence corporate activities but currently has no specific plans for extraordinary transactions such as mergers or liquidations. The ownership calculation is based on 46,838,962 shares of common stock outstanding.